30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2014: A Recap of Strategic Activities in Arthroscopy/Soft Tissue Repair

Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015.

To begin 2015, let’s look back at what fueled growth in 2014 in arthroscopy and soft tissue repair. Here, we present companies that have merged and emerged, products that launched, projects that received funding. (Please note, ORTHOKNOW July 2014 features a review of 1H14 funding activity.)

Lending perspective from your peers, this issue includes insights gathered at the 2014 Musculoskeletal New Ventures Conference, as well. See companion articles, “Business Development Execs Speak on M&A and Innovation” and “Industry Investments Stay Steady, Focus on Established Technologies.”

Start-ups, spin-outs and subsidiaries identified during 2014 included:

GEN2 Medical
Cleveland, Ohio, USA

  • Formed to import, manufacture and sell instruments and devices for use in all surgical specialties, with a primary focus on neurosurgery, orthopaedics and spine
  • Also partners with surgeon inventors to support more control over product development
  • Exclusive U.S. distributor of Rebstock spinal instruments from Germany


M&A Activity in 2014:

ORTHOWORLD’s Merger & Acquisition database recorded 41 transactions in 2014. The table below captures select OEM activities with arthroscopy/soft tissue applications; visit the M&A database to see all 41, including numerous deals among suppliers.

Acquiring Company Acquired Company
Aastrom Biosciences (now Vericel) Sanofi Cell Therapy and Regenerative Medicine cell therapies
Smith & Nephew  ArthroCare arthroscopy/soft tissue, etc.
Stryker Pivot Medical hip arthroscopy

Fundings identified during 2H14 included:

Rotation Medical secured $27.2MM in an oversubscribed Series B financing

  • To support commercial launch, post-market studies of treatment for rotator cuff disease

Trice Medical closed 1st tranche of a $11.6MM Series B financing

  • To support commercialization of mi-eye™ single-use visualization device to perform diagnostic arthroscopy in the physician’s office during initial consultation

Surgical Frontiers closed a $7MM fund

  • To invest in its incubator focused upon musculoskeletal surgical technology start-ups
  • Initial funding commitments have been made to 3 portfolio companies addressing foot/ankle, sports medicine and trauma

Product launches in 2014 included:

Biomet Sports Medicine
JuggerKnotless Soft Anchor

  • All-suture knotless device for labral repair in the shoulder
  • 2.1mm drill hole preserves bone, allows more freedom in anchor placement
  • Demonstrated 57 lbs. of pullout strength

A portion of this article appeared in the December 2014 issue of BONEZONE®.

Sources: Company press releases, earnings calls, filings with the U.S. Securities and Exchange Commission, company web sites, articles in the public domain, etc.

Search content by market segment here.